| Title |
Increased Expression of Thymidylate Synthetase (TS), Ubiquitin Specific Protease 10 (USP10) and Survivin is Associated with Poor Survival in Glioblastoma Multiforme (GBM)
|
|---|---|
| Published in |
Journal of Neuro-Oncology, June 2006
|
| DOI | 10.1007/s11060-006-9191-4 |
| Pubmed ID | |
| Authors |
Jessica M. Grunda, L. Burton Nabors, Cheryl A. Palmer, David C. Chhieng, Adam Steg, Tom Mikkelsen, Robert B. Diasio, Kui Zhang, David Allison, William E. Grizzle, Wenquan Wang, G. Yancey Gillespie, Martin R. Johnson |
| Abstract |
The limited success of empirically designed treatment paradigms for patients diagnosed with glioblastoma multiforme (GBM) emphasizes the need for rationally designed treatment strategies based on the molecular profile of tumor samples and their correlation to clinical parameters. |
Mendeley readers
The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 2% |
| Unknown | 43 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 23% |
| Other | 5 | 11% |
| Student > Ph. D. Student | 4 | 9% |
| Student > Master | 3 | 7% |
| Student > Bachelor | 3 | 7% |
| Other | 5 | 11% |
| Unknown | 14 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 11 | 25% |
| Medicine and Dentistry | 11 | 25% |
| Biochemistry, Genetics and Molecular Biology | 3 | 7% |
| Neuroscience | 2 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 15 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 October 2023.
All research outputs
#3,272,356
of 22,788,370 outputs
Outputs from Journal of Neuro-Oncology
#265
of 2,967 outputs
Outputs of similar age
#6,926
of 64,442 outputs
Outputs of similar age from Journal of Neuro-Oncology
#2
of 12 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,967 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 64,442 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.